The Ultimate Guide to a Life Sciences IPO

The life sciences industry is in the middle of an IPO boom, with the 10 highest-valued biotech IPOs raising $3.


Meet Kelly Provost: A Leader in CFGI’s Life Sciences Capital Markets

Kelly Provost is a leader in CFGI’s Life Sciences Capital Markets practice and has dedicated her career to supporting companies that are trying to cure diseases and save lives, making a difference in the lives of people across the world.


Meet Melanie Kavanagh: A Committed Accounting and Finance Leader at CFGI’s SF Office

Melanie Kavanagh’s promotion to Partner has been an achievement in the making since the day she walked in the doors at CFGI in 2012.


Case Study: Reverse Acquisition between Private Operating Company and Public Registrant

The Future Is Already Here, and CFOs Need to Transform Finance to Survive

Download the Whitepaper

Case Study: Initial Public Offering of Foreign Medical Diagnostic Company

Case Study: Initial Public Offering of a Clinical Stage Biotech

Case Study: Acquisition Support for Clinical Research Organization

Whitepaper: Private Equity – Current and emerging financial due diligence considerations when acquiring physician practices

As PE acquisitions of healthcare businesses have surged over the past decade, investments in physician practices and physician practice management (PPM) companies have accelerated apace.